Abstract

IntroductionLupus anticoagulant (LAC) testing is challenging. Most data are derived from a well-controlled study environment with potential alterations to daily routines. The aim of this retrospective cohort study was to assess the capacity of various LAC screening tests and derived mixing tests to predict a positive result in subsequent confirmation tests in a large cohort of patients.Materials and methodsIn 5832 individuals, we retrospectively evaluated the accuracy of the aPTT-A, aPTT-LAscreen, aPTT-FS and dRVVTscreen and of their derived mixing tests in detecting a positive confirmation test result within the same blood specimen. The group differences, degree of correlation and the predictive accuracy of LAC coagulation tests were analysed using the Mann-Whitney U test, the Spearman-rank-correlation and by area under the receiver operating characteristic curve (ROC-AUC) analysis. ROC-AUCs were compared with the Venkatraman´s permutation test.ResultsThe pre-test probability of patients with clinically suspected LAC was 36% in patients without factor deficiency or anticoagulation therapy. The aPTT-LAscreen showed the best diagnostic accuracy with a ROC-AUC of 0.84 (95% CI: 0.82 – 0.86). No clear advantage of the dRVVT-derived mixing test was detectable when compared to the dRVVTscreen (P = 0.829). Usage of the index of circulating anticoagulant (ICA) did not improve the diagnostic power of respective mixing tests.ConclusionsAmong the parameters evaluated, aPTT-LAscreen and derived mixing test parameters were the most accurate tests. In our study cohort, neither other mixing test nor the ICA presented any further advantage in LAC diagnostics.

Highlights

  • The aPTT-LAscreen showed the best diagnostic accuracy with a ROC-AUC of 0.84

  • Neither other mixing test nor the index of circulating anticoagulant (ICA) presented any further advantage in lupus anticoagulants (LAC) diagnostics

  • Since no individual screening test presents with a high diagnostic accuracy, most guidelines recommend the performance of two tests for the initial screening, including a test based on the diluted Russell Viper venom time and a LAC-sensitive activated partial thromboplastin time containing low amounts of phospholipids

Read more

Summary

Introduction

Most data are derived from a well-controlled study environment with potential alterations to daily routines The aim of this retrospective cohort study was to assess the capacity of various LAC screening tests and derived mixing tests to predict a positive result in subsequent confirmation tests in a large cohort of patients. The detection of lupus anticoagulants (LAC) is based on interference testing of the coagulation cascade and testing it proves challenging [1]. Since no individual screening test presents with a high diagnostic accuracy, most guidelines recommend the performance of two tests for the initial screening, including a test based on the diluted Russell Viper venom time (dRVVT) and a LAC-sensitive activated partial thromboplastin time (aPTT-LAscreen) containing low amounts of phospholipids.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call